Skip to main content
Top
Published in: Neurological Sciences 9/2020

Open Access 01-09-2020 | Amyotrophic Lateral Sclerosis | Original Article

Transcranial sonography changes in heterozygotic carriers of the ATP7B gene

Authors: Marta Skowronska, Tomasz Litwin, Iwona Kurkowska-Jastrzębska, Anna Członkowska

Published in: Neurological Sciences | Issue 9/2020

Login to get access

Abstract

Purpose

Wilson’s disease (WD) is an autosomal recessive disorder of ATP7B gene leading to impaired copper metabolism. Brain imaging, such as magnetic resonance (MR) and transcranial sonography (TCS) in WD patients, shows changes mostly in the basal ganglia. Heterozygotic carriers of one faulty ATP7B gene should not exhibit symptoms of WD, but one in three heterozygotes has copper metabolism abnormalities. This study examined heterozygote ATP7B mutation carriers using TCS to assess any basal ganglia changes compared with healthy controls.

Methods

Heterozygote carriers and healthy volunteers underwent the same standard MR and TCS imaging protocols. Heterozygotes were followed for 5 years and monitored for the development of neurological symptoms.

Results

The study assessed 34 heterozygotes (21 women), with mean age of 43 years (range of 18 to 74 years) and 18 healthy controls (13 women), with mean age of 47 years (range of 20 to 73 years). Bilateral lenticular nucleus (LN) hyperechogenicity was found in 25 heterozygotes, but none of the controls (p < 0.001). Bilateral substantia nigra (SN) hyperechogenicity was found in 8 heterozygotes and one control; another 3 heterozygotes had unilateral SN hyperechogenicity (p = 0.039 for the right; p = 0.176 for the left). Heterozygotes had larger SN area on both sides compared with controls (p = 0.005 right; p = 0.008 left).

Conclusions

SN and LN hyperechogenicity were more frequent in heterozygotes than in controls, probably due to copper accumulation, but it remains unknown if this predisposes to brain neurodegeneration.
Literature
1.
go back to reference Członkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, Rybakowski JK, Weiss KH, Schilsky ML (2018) Wilson disease. Nat Rev Dis Primers 4(1):21PubMedPubMedCentral Członkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, Rybakowski JK, Weiss KH, Schilsky ML (2018) Wilson disease. Nat Rev Dis Primers 4(1):21PubMedPubMedCentral
2.
go back to reference Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML (2007) Wilson's disease. Lancet 369(9559):397–408PubMed Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML (2007) Wilson's disease. Lancet 369(9559):397–408PubMed
3.
go back to reference King AD, Walshe JM, Kendall BE, Chinn RJ, Paley MN, Wilkinson ID, Halligan S, Hall-Craggs MA (1996) Cranial MR imaging in Wilson’s disease. AJR Am J Roentgenol 167(6):1579–1584PubMed King AD, Walshe JM, Kendall BE, Chinn RJ, Paley MN, Wilkinson ID, Halligan S, Hall-Craggs MA (1996) Cranial MR imaging in Wilson’s disease. AJR Am J Roentgenol 167(6):1579–1584PubMed
4.
go back to reference Saatci I, Topcu M, Baltaoglu FF, Köse G, Yalaz K, Renda Y, Besim A (1997) Cranial MR findings in Wilson’s disease. Acta Radiol 38(2):250–258PubMed Saatci I, Topcu M, Baltaoglu FF, Köse G, Yalaz K, Renda Y, Besim A (1997) Cranial MR findings in Wilson’s disease. Acta Radiol 38(2):250–258PubMed
5.
go back to reference Kozić D, Svetel M, Petrović B, Dragasević N, Semnic R, Kostić VS (2003) MR imaging of the brain in patients with hepatic form of Wilson’s disease. Eur J Neurol 10(5):587–592PubMed Kozić D, Svetel M, Petrović B, Dragasević N, Semnic R, Kostić VS (2003) MR imaging of the brain in patients with hepatic form of Wilson’s disease. Eur J Neurol 10(5):587–592PubMed
6.
go back to reference Prashanth LK, Sinha S, Taly AB, Vasudev MK (2010) Do MRI features distinguish Wilson's disease from other early onset extrapyramidal disorders? An analysis of 100 cases. Mov Disord 25(6):672–678PubMed Prashanth LK, Sinha S, Taly AB, Vasudev MK (2010) Do MRI features distinguish Wilson's disease from other early onset extrapyramidal disorders? An analysis of 100 cases. Mov Disord 25(6):672–678PubMed
7.
go back to reference Dusek P, Skoloudik D, Maskova J, Huelnhagen T, Bruha R, Zahorakova D, Niendorf T, Ruzicka E, Schneider SA, Wuerfel J (2018) Brain iron accumulation in Wilson's disease: a longitudinal imaging case study during anticopper treatment using 7.0T MRI and transcranial sonography. J Magn Reson Imaging 47(1):282–285PubMed Dusek P, Skoloudik D, Maskova J, Huelnhagen T, Bruha R, Zahorakova D, Niendorf T, Ruzicka E, Schneider SA, Wuerfel J (2018) Brain iron accumulation in Wilson's disease: a longitudinal imaging case study during anticopper treatment using 7.0T MRI and transcranial sonography. J Magn Reson Imaging 47(1):282–285PubMed
8.
go back to reference Walter U, Krolikowski K, Tarnacka B, Benecke R, Czlonkowska A, Dressler D (2005) Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology 64(10):1726–1732PubMed Walter U, Krolikowski K, Tarnacka B, Benecke R, Czlonkowska A, Dressler D (2005) Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology 64(10):1726–1732PubMed
9.
go back to reference Svetel M, Mijajlovi M, Tomi A, Kresojevi PT, Kosti VS (2012) Transcranial sonography in Wilson’s disease. Parkinsonism Relat Disord 18(3):234–238PubMed Svetel M, Mijajlovi M, Tomi A, Kresojevi PT, Kosti VS (2012) Transcranial sonography in Wilson’s disease. Parkinsonism Relat Disord 18(3):234–238PubMed
10.
go back to reference Tribl GG, Trindade MC, Almeida KJ, Alves RC, de Andrade DC, Fonoff ET, Machado AA, Teixeira MJ, Barbosa ER, Bor-Seng-Shu E (2018) Quantitative transcranial sonography in Wilson's disease and healthy controls: cut-off values and functional correlates. J Neurol Sci 385:69–74PubMed Tribl GG, Trindade MC, Almeida KJ, Alves RC, de Andrade DC, Fonoff ET, Machado AA, Teixeira MJ, Barbosa ER, Bor-Seng-Shu E (2018) Quantitative transcranial sonography in Wilson's disease and healthy controls: cut-off values and functional correlates. J Neurol Sci 385:69–74PubMed
11.
go back to reference Johnson S (2001) Is Parkinson’s disease the heterozygote form of Wilson’s disease: PD=1/2 WD? Med Hypotheses 56(2):171–173PubMed Johnson S (2001) Is Parkinson’s disease the heterozygote form of Wilson’s disease: PD=1/2 WD? Med Hypotheses 56(2):171–173PubMed
13.
go back to reference Coffey AJ, Durkie M, Hague S, McLay K, Emmerson J, Lo C, Klaffke S, Joyce CJ, Dhawan A, Hadzic N, Mieli-Vergani G, Kirk R, Elizabeth Allen K, Nicholl D, Wong S, Griffiths W, Smithson S, Giffin N, Taha A, Connolly S, Gillett GT, Tanner S, Bonham J, Sharrack B, Palotie A, Rattray M, Dalton A, Bandmann O (2013) A genetic study of Wilson’s disease in the United Kingdom. Brain 136(Pt 5):1476–1487PubMedPubMedCentral Coffey AJ, Durkie M, Hague S, McLay K, Emmerson J, Lo C, Klaffke S, Joyce CJ, Dhawan A, Hadzic N, Mieli-Vergani G, Kirk R, Elizabeth Allen K, Nicholl D, Wong S, Griffiths W, Smithson S, Giffin N, Taha A, Connolly S, Gillett GT, Tanner S, Bonham J, Sharrack B, Palotie A, Rattray M, Dalton A, Bandmann O (2013) A genetic study of Wilson’s disease in the United Kingdom. Brain 136(Pt 5):1476–1487PubMedPubMedCentral
14.
go back to reference Gromadzka G, Chabik G, Mendel T, Wierzchowska A, Rudnicka M, Czlonkowska A (2010) Middle-aged heterozygous carriers of Wilson’s disease do not present with significant phenotypic deviations related to copper metabolism. J Genet 89(4):463–467PubMed Gromadzka G, Chabik G, Mendel T, Wierzchowska A, Rudnicka M, Czlonkowska A (2010) Middle-aged heterozygous carriers of Wilson’s disease do not present with significant phenotypic deviations related to copper metabolism. J Genet 89(4):463–467PubMed
15.
go back to reference Okada T, Shiono Y, Hayashi H, Satoh H, Sawada T, Suzuki A, Takeda Y, Yano M, Michitaka K, Onji M, Mabuchi H (2000) Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson’s disease. Hum Mutat 15(5):454–462PubMed Okada T, Shiono Y, Hayashi H, Satoh H, Sawada T, Suzuki A, Takeda Y, Yano M, Michitaka K, Onji M, Mabuchi H (2000) Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson’s disease. Hum Mutat 15(5):454–462PubMed
16.
go back to reference Gibbs K, Walshe JM (1979) A study of the caeruloplasmin concentrations found in 75 patients with Wilson’s disease, their kinships and various control groups. Q J Med 48(191):447–463PubMed Gibbs K, Walshe JM (1979) A study of the caeruloplasmin concentrations found in 75 patients with Wilson’s disease, their kinships and various control groups. Q J Med 48(191):447–463PubMed
17.
go back to reference Tarnacka B, Szeszkowski W, Buettner J, Gołębiowski M, Gromadzka G, Członkowska A (2009) Heterozygous carriers for Wilson’s disease-magnetic spectroscopy changes in the brain. Metab Brain Dis 24(3):463–468PubMed Tarnacka B, Szeszkowski W, Buettner J, Gołębiowski M, Gromadzka G, Członkowska A (2009) Heterozygous carriers for Wilson’s disease-magnetic spectroscopy changes in the brain. Metab Brain Dis 24(3):463–468PubMed
18.
go back to reference Gaenslen A, Unmuth B, Godau J, Liepelt I, Di Santo A, Schweitzer KJ, Gasser T, Machulla HJ, Reimold M, Marek K, Berg D (2008) The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson’s disease: a prospective blinded study. Lancet Neurol 7(5):417–424PubMed Gaenslen A, Unmuth B, Godau J, Liepelt I, Di Santo A, Schweitzer KJ, Gasser T, Machulla HJ, Reimold M, Marek K, Berg D (2008) The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson’s disease: a prospective blinded study. Lancet Neurol 7(5):417–424PubMed
19.
go back to reference Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7(11):1044–1055PubMed Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7(11):1044–1055PubMed
20.
go back to reference Berg D, Behnke S, Seppi K, Godau J, Lerche S, Mahlknecht P, Liepelt-Scarfone I, Pausch C, Schneider N, Gaenslen A, Brockmann K, Srulijes K, Huber H, Wurster I, Stockner H, Kiechl S, Willeit J, Gasperi A, Fassbender K, Gasser T, Poewe W (2013) Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson’s disease. Mov Disord 28(2):216–219PubMed Berg D, Behnke S, Seppi K, Godau J, Lerche S, Mahlknecht P, Liepelt-Scarfone I, Pausch C, Schneider N, Gaenslen A, Brockmann K, Srulijes K, Huber H, Wurster I, Stockner H, Kiechl S, Willeit J, Gasperi A, Fassbender K, Gasser T, Poewe W (2013) Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson’s disease. Mov Disord 28(2):216–219PubMed
21.
go back to reference Fathinia P, Hermann A, Reuner U, Kassubek J, Storch A, Ludolph AC (2013) Parkinson’s disease-like midbrain hyperechogenicity is frequent in amyotrophic lateral sclerosis. J Neurol 260(2):454–457PubMed Fathinia P, Hermann A, Reuner U, Kassubek J, Storch A, Ludolph AC (2013) Parkinson’s disease-like midbrain hyperechogenicity is frequent in amyotrophic lateral sclerosis. J Neurol 260(2):454–457PubMed
22.
go back to reference Berg D, Roggendorf W, Schröder U, Klein R, Tatschner T, Benz P, Tucha O, Preier M, Lange KW, Reiners K, Gerlach M, Becker G (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59(6):999–1005PubMed Berg D, Roggendorf W, Schröder U, Klein R, Tatschner T, Benz P, Tucha O, Preier M, Lange KW, Reiners K, Gerlach M, Becker G (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59(6):999–1005PubMed
23.
go back to reference Kostic VS, Svetel M, Mijajlovic M, Pavlovic A, Jecmenica-Lukic M, Kozic D (2012) Transcranial sonography in pantothenate kinase-associated neurodegeneration. J Neurol 259(5):959–964PubMed Kostic VS, Svetel M, Mijajlovic M, Pavlovic A, Jecmenica-Lukic M, Kozic D (2012) Transcranial sonography in pantothenate kinase-associated neurodegeneration. J Neurol 259(5):959–964PubMed
24.
go back to reference Skowronska M, Kmiec T, Czlonkowska A, Kurkowska-Jastrzebska I (2018) Transcranial Sonography in mitochondrial membrane protein-associated Neurodegeneration. Clin Neuroradiol 28(3):385–392PubMed Skowronska M, Kmiec T, Czlonkowska A, Kurkowska-Jastrzebska I (2018) Transcranial Sonography in mitochondrial membrane protein-associated Neurodegeneration. Clin Neuroradiol 28(3):385–392PubMed
25.
go back to reference Walter U, Skowrońska M, Litwin T, Szpak GM, Jabłonka-Salach K, Skoloudík D, Bulska E, Członkowska A (2014) Lenticular nucleus hyperechogenicity in Wilson’s disease reflects local copper, but not iron accumulation. J Neural Transm 121(10):1273–1279PubMed Walter U, Skowrońska M, Litwin T, Szpak GM, Jabłonka-Salach K, Skoloudík D, Bulska E, Członkowska A (2014) Lenticular nucleus hyperechogenicity in Wilson’s disease reflects local copper, but not iron accumulation. J Neural Transm 121(10):1273–1279PubMed
26.
go back to reference Walter U, Dressler D, Lindemann C, Slachevsky A, Miranda M (2008) Transcranial sonography findings in welding-related parkinsonism in comparison to Parkinson’s disease. Mov Disord 23(1):141–145PubMed Walter U, Dressler D, Lindemann C, Slachevsky A, Miranda M (2008) Transcranial sonography findings in welding-related parkinsonism in comparison to Parkinson’s disease. Mov Disord 23(1):141–145PubMed
27.
go back to reference Skowronska M, Dzieżyc K, Czlonkowska A (2014) Transcranial sonography in manganese-induced parkinsonism caused by drug abuse. Clin Neuroradiol 24(4):385–387PubMed Skowronska M, Dzieżyc K, Czlonkowska A (2014) Transcranial sonography in manganese-induced parkinsonism caused by drug abuse. Clin Neuroradiol 24(4):385–387PubMed
28.
go back to reference Becker G, Berg D, Rausch WD, Lange HK, Riederer P, Reiners K (1999) Increased tissue copper and manganese content in the lentiform nucleus in primary adult-onset dystonia. Ann Neurol 46(2):260–263PubMed Becker G, Berg D, Rausch WD, Lange HK, Riederer P, Reiners K (1999) Increased tissue copper and manganese content in the lentiform nucleus in primary adult-onset dystonia. Ann Neurol 46(2):260–263PubMed
29.
go back to reference Naumann M, Becker G, Toyka KV, Supprian T, Reiners K (1996) Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology 47(5):1284–1290PubMed Naumann M, Becker G, Toyka KV, Supprian T, Reiners K (1996) Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology 47(5):1284–1290PubMed
30.
go back to reference Becker G, Naumann M, Scheubeck M, Hofmann E, Deimling M, Lindner A, Gahn G, Reiners C, Toyka KV, Reiners K (1997) Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis. Mov Disord 12:79–88PubMed Becker G, Naumann M, Scheubeck M, Hofmann E, Deimling M, Lindner A, Gahn G, Reiners C, Toyka KV, Reiners K (1997) Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis. Mov Disord 12:79–88PubMed
31.
go back to reference Sadowski K, Szlachta K, Serafin-Król M, Gałązka-Friedman J, Friedman A (2012) Brain tissue echogenicity-implications for substantia nigra studies in parkinsonian patients. J Neural Transm 119(3):363–367PubMed Sadowski K, Szlachta K, Serafin-Król M, Gałązka-Friedman J, Friedman A (2012) Brain tissue echogenicity-implications for substantia nigra studies in parkinsonian patients. J Neural Transm 119(3):363–367PubMed
Metadata
Title
Transcranial sonography changes in heterozygotic carriers of the ATP7B gene
Authors
Marta Skowronska
Tomasz Litwin
Iwona Kurkowska-Jastrzębska
Anna Członkowska
Publication date
01-09-2020
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 9/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04378-6

Other articles of this Issue 9/2020

Neurological Sciences 9/2020 Go to the issue